8Stampfer MJ, Mahinow MR, Willet WC, et al. A prospective study of plasma homecysteine and risk of myocardial infarction in US Physicians [ J ]. JAMA, 1992,268 (7): 877- 881.
9Boushey C J, Beresford S A , Omcnn G S, et al, A quantitative assessment of plasm homocysteine as a rist for factor vascular disease [ J ]. JAMA, 1995,274:1049 - 1057.
10Chiu, H. F. K, Lam, L. C. W, Chi, I, et al, Prevalence of Dementia in Chinese Elderly in Hong Kong [ J ]. Neurology, 1998,50(4) :1002 - 1009.
二级参考文献36
1Glueck C J，Am J Cardiol，1995年，75卷，15期，132页
2Jun Hyunyoo，Stroke，1998年，29卷，2478页
3SUNSAN C, LOUIS M, VIVIAN F. Hyperhomocysteinemia: an emerging and important risk factor for thromboembolic and Cardiovascular disease[J]. Clin Chem. 1996, 106: 709.
4JACOB RA, WU MM, HENING SM, et al. Homocysteine increases as fo late decreases in plasma of healtty men during short-term dietary folate and methyl group restriction[J]. J Nutr, 1994, 124: 1072.
5HOOGEVEEN EK, KOSTENSE PJ, BEKS PJ, et al. Hyperhomocysteinemia is associated with an increased rick of card iovascular disease, especially in noninsulin-dependent diabetes mellitus: a population-based study[J]. Arterio scler Thromb Vasc BIOL, 1998, 18: 133.
6STEM JM, SAVER JL, BOLDY RM. Homocysteine as sociatea hypercoagulab ility and disseminated thrombosis a case report[J]. an giology, 1998, 49:765.
7FRANTZEN F, FAAREN AL, ALFHEIM I, et al. Enzyme conversion immu noassay for determining total homocysteine in plasma or serum[J]. Clin chem, 1 998, 44:311.
8NEDREBO BG, ERICSSON UB, NYGARD O, et al. plasma total homocyst eine levels in hyperthyroid and hypothyroid patients[J]. Metabolism, 1998, 47: 89.
9PEMA AF, CASTALDO P, INGROSSO D, et al. Homocysteine, a new car diovascular risk factor[J]. J Nephrol, 1999, 12:23.
10Biasioli S, Schiavon R. Homocysteine as a cardiovascular risk factor. Blood Purif, 2000, 18 (3): 177-182
8Fallon UB, Virtamo J, Young I, et al. Homocysteine and cerebral infarction in finnish male smokers [ J]. Stroke, 2003, 34(6) :1 359.
9Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death : the vitamin intervention for stroke prevention (VISP)randomized controlled trial[J]. JAMA ,2004,291(5):565.
10Kannel WB. Coronary heart disease risk factors in the elderly [ J ]. Am J Geriatr Cardiol, 2002,11 (2) : 101.
